Moneycontrol PRO
Outskill Genai
HomeNewsTrendsHealthSurge in COVID-19 cases across India; Mumbai, Bengaluru Urban, Kolkata, among districts of concern: Health Ministry

Surge in COVID-19 cases across India; Mumbai, Bengaluru Urban, Kolkata, among districts of concern: Health Ministry

The COVID-19 case positivity across the country rose from 1.1 per cent on December 30 to 11.05 per cent on January 12, the Ministry said.

January 12, 2022 / 17:08 IST
Representational image: Reuters

India is witnessing a sharp surge in COVID-19 cases with Mumbai, Bengaluru Urban, Thane, Kolkata, Chennai, Pune emerging as districts of concern, the Union Health Ministry said on January 12.

The case positivity rose from 1.1 percent on December 30 to 11.05 percent on January 12, the Ministry said.

Catch all live updates on Coronavirus Omicron on our Live Blog here

"India is witnessing a sharp surge in COVID-19 cases. The emerging states of concern reporting surge in COVID-19 cases are Maharashtra, West Bengal, Delhi, Tamil Nadu, Karnataka, Uttar Pradesh, Kerala, and Gujarat," said Lav Agarwal, Joint Secretary, Health Ministry.

The country on January 12 recorded 1,94,720 fresh COVID-19 cases and 442 deaths in the last 24 hours. The active cases increased to 9,55,319, the highest in 211 days. The daily positivity rate increased to 11.05 percent.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

READ: Demand for plots and independent floors stages strong comeback in pandemic, overtakes apartments

The Ministry said while  115 confirmed deaths have been reported globally due to Omicron, one death has taken place in India due to the new variant of COVID-19.

"The high surge in cases is being reported globally in as many as 159 countries. Eight countries in Europe are reporting an increase of cases by more than two times in the last two weeks," Agarwal said.

The Omicron variant has a substantial growth advantage over the Delta variant as per World Health Organisation (WHO), the Ministry said.

"Data from South Africa, UK, Canada, Denmark suggests a reduced risk of hospitalization for Omicron compared to Delta," Agarwal said.

Also, read: Flipkart, 1MG report surge in demand for oximeters and testing kits as COVID-19 cases rise

Earlier in the day, Prime Minister Narendra Modi said that over 2o million children in the age group 15-18 years have been vaccinated against COVID-19 so far. The PM praised the sense of responsibility of the youth that, he said, was evident from the fast pace of vaccination in the drive that started on January 3.

The Ministry cited data from New York in the USA to show how vaccines work against infection and hospitalisation. "Fully vaccinated people have 78 percent lower chance of getting infected," Agarwal said.

The Health Ministry said that after a review meeting by Prime Minister Narendra Modi on the COVID-19 situation, the government has on January 9 revised discharge policy with severity categorised into mild and moderate cases.

"Mild cases will be discharged after at least seven days from testing positive and non-emergency for three successive days. There is no need for testing prior to discharge," Agarwal said.

Also, read: COVID-19 | FICCI writes to Health Minister Mansukh Mandaviya, makes recommendations for tackling virus surge

In case of moderate infection, if there is the resolution of symptoms and the patient's Oxygen saturation level stays above 93 percent for three successive days, then such patients will be discharged, he said.

The Ministry urged that there should be a rational approach for medicine use.

"We are concerned about the overuse and misuse of drugs. Don't overuse, it will have aftermath," Dr. VK Paul, Niti Aayog Member (Health) insisting that people need to be careful since the Omicron variant is not a common cold. The fact remains that vaccination remains a critical aspect of our response, he said.

Gulam Jeelani
Gulam Jeelani is a journalist with over 12 years of reporting experience. Based in New Delhi, he covers politics and governance for Moneycontrol.
first published: Jan 12, 2022 05:08 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347